Newstral
Article
NZ Herald on 2020-06-16 03:09
Continuous Disclosure: Market moves for Aroa Biosurgery, Fonterra and Abano
Related news
- Continuous Disclosure: Fonterra exits Beingmate JV, Super Fund calls for dam safety clampdownNZ Herald
- Continuous Disclosure: ANZ sounds Fonterra warning, mystery IPO in the windNZ Herald
- Damien Venuto: Fonterra, Kiwibank, Sport NZ make marketing movesNZ Herald
- Coronavirus crisis cuts continuous disclosure down to sizeSydney Morning Herald
- Continuous Disclosure: Large block of Ebos shares on the marketNZ Herald
- Fonterra top job appointment sends strong message to the marketNZ Herald
- Fonterra maintains grip on raw milk market despite predictionsNZ Herald
- Continuous Disclosure: Too much capital for Tower? Fonterra's curious $62m debtNZ Herald
- Fonterra moves to next stage of green electricity storage trialNZ Herald
- FFonterra moves on baby formulafarmweekly.com.au
- UMilk Protein Concentrate Market Insights – Growth, Challenges and Future Scope to 2027| Fonterra, Westland, Nutrinnovate Australia, Taturaunlvrebelyell.com
- Continuous disclosure relief: temporary and limitedjdsupra.com
- Continuous Disclosure: John Key joins Palo AltoNZ Herald
- Continuous Disclosure: Airport shares flying too high?NZ Herald
- CSA Continuous Disclosure Review Program Highlights Common Disclosure Deficienciesjdsupra.com
- SFonterra profit surgesstockandland.com.au
- SFonterra sells Bega stakestockandland.com.au
- Fonterra drops price guaranteeNZ Herald
- Fonterra begins restructure consultationsNZ Herald
- Fonterra cuts payout forecastNZ Herald